BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
TGFB1
,
Angiogenesis
,
Lung cancer
,
Embryo
,
Nosology
,
Acetaminophen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phorbolol myristate acetate
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SPP1
CD52
CD9
EMP1
EGR2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
PUJANA_BRCA1_PCC_NETWORK
DODD_NASOPHARYNGEAL_CARCINOMA_DN
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
LEE_BMP2_TARGETS_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Th1 and Th17 CD4+ T cell lineages
CD4+ T cell and Th2-polarized cell gene expression regulated by the SWI/SNF subunit BAF180
Effects of gene silencing of USP2 on expression profiles of HL60 cells
U937 histiocytic cell line - polysomal and cytoplasmic RNA induction by the phorbol ester PMA
MM6 monocytes - activation-induced gene expression in cyclinT1-depleted cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Equine ELISPOT assay to study secretion of IFNγ and IL-4 from peripheral blood mononuclear cells.
Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation.
Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blockin…
Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant…
PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for phorbolol myristate acetate
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ